Publication

Article

Pharmacy Times

August 2019 Back to School
Volume85
Issue 8

The Role of the Pharmacist With Cholesterol Management: Focusing on New Guidelines and PCSK9 Inhibitors

Continuing education for managing cholesterol with PCSK9 inhibitors.

Faculty

Joseph J. Saseen, PharmD, BCPS, BCACP, CLS, Professor and Vice Chair, Department of Clinical Pharmacy; Professor, Department of Family Medicine; University of Colorado Anschutz Medical Campus, Aurora Colorado

Educational Objectives

At the completion of this activity, the participant will be able to:

  • Examine the pathophysiology, complications, and burden associated with hypercholesterolemia
  • Identify updates to guidelines and the appropriate role of PCSK9 inhibitors in the management of hypercholesterolemia
  • Explore various ways that pharmacists can make an impact and provide education for patients with hypercholesteremia to optimize outcomes

Target Audience: Pharmacists

Activity Type: Application

Release Date: August 12, 2019

Expiration Date: August 12, 2020

Estimated Time to Complete Activity: 2.0 hours

Fee: This lesson is offered for free at www.pharmacytimes.org

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs